Pediatric Gastroenterology, Hepatology & Nutrition

  • 제19권2호
  • /
  • Pages.147-151
  • /
  • 2016
  • /
  • 2234-8646(pISSN)
  • /
  • 2234-8840(eISSN)
대한소아소화기영양학회 (The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition)
권호 표지
DOI QR코드

DOI QR Code

Living Related Liver Transplantation in an Infant with Neonatal Hemochromatosis

  • Choi, Shin Jie (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Choi, Jong Sub (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Chun, Peter (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Yoo, Jung Kyung (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Moon, Jin Soo (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Ko, Jae Sung (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Kim, Woo Sun (Department of Radiology, Seoul National University College of Medicine) ;
  • Kang, Gyeong Hoon (Department of Pathology, Seoul National University College of Medicine) ;
  • Yi, Nam-Joon (Department of Surgery, Seoul National University College of Medicine)
  • 투고 : 2015.06.05
  • 심사 : 2015.08.12
  • 발행 : 2016.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Neonatal hemochromatosis (NH) is a severe neonatal liver injury that is confirmed by extra-hepatic iron accumulation. Although a recent study described treating NH with exchange transfusions and intravenous immunoglobulin, liver transplantation should be considered for patients with severe liver failure that does not respond to other medical treatment. Herein, we report the case of a two-month-old female infant who presented with persistent ascites and hyperbilirubinemia. Her laboratory findings demonstrated severe coagulopathy, high indirect and direct bilirubin levels, and high ferritin levels. Abdominal magnetic resonance imaging presented low signal intensity in the liver on T2-weighted images, suggesting iron deposition. The infant was diagnosed with NH as a result of the clinical findings and after congenital infection and metabolic diseases were excluded. The infant was successfully treated with a living-donor liver transplantation. Living related liver transplantation should be considered as a treatment option for NH in infants.

키워드

참고문헌

  1. Whitington PF. Fetal and infantile hemochromatosis. Hepatology 2006;43:654-60. https://doi.org/10.1002/hep.21129
  2. Lopriore E, Mearin ML, Oepkes D, Devlieger R, Whitington PF. Neonatal hemochromatosis: management, outcome, and prevention. Prenat Diagn 2013;33: 1221-5. https://doi.org/10.1002/pd.4232
  3. Whitington PF. Gestational alloimmune liver disease and neonatal hemochromatosis. Semin Liver Dis 2012;32:325-32.
  4. Pan X, Kelly S, Melin-Aldana H, Malladi P, Whitington PF. Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade. Hepatology 2010;51:2061-8. https://doi.org/10.1002/hep.23581
  5. Whitington PF, Kelly S. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics 2008;121:e1615-21. https://doi.org/10.1542/peds.2007-3107
  6. Whitington PF, Hibbard JU. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 2004;364:1690-8. https://doi.org/10.1016/S0140-6736(04)17356-X
  7. Bailey D, Colantonio D, Kyriakopoulou L, Cohen AH, Chan MK, Armbruster D, et al. Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort. Clin Chem 2013;59:1393-405. https://doi.org/10.1373/clinchem.2013.204222
  8. Soldin OP, Dahlin JR, Gresham EG, King J, Soldin SJ. IMMULITE 2000 age and sex-specific reference intervals for alpha fetoprotein, homocysteine, insulin, insulin- like growth factor-1, insulin-like growth factor binding protein-3, C-peptide, immunoglobulin E and intact parathyroid hormone. Clin Biochem 2008;41: 937-42. https://doi.org/10.1016/j.clinbiochem.2008.04.025
  9. Deugnier Y, Turlin B. Pathology of hepatic iron overload. Semin Liver Dis 2011;31:260-71. https://doi.org/10.1055/s-0031-1286057
  10. Whitington PF, Kelly S, Ekong UD. Neonatal hemochromatosis: fetal liver disease leading to liver failure in the fetus and newborn. Pediatr Transplant 2005;9: 640-5. https://doi.org/10.1111/j.1399-3046.2005.00357.x
  11. Knisely AS, O'Shea PA, Stocks JF, Dimmick JE. Oropharyngeal and upper respiratory tract mucosal-gland siderosis in neonatal hemochromatosis: an approach to biopsy diagnosis. J Pediatr 1988;113:871-4. https://doi.org/10.1016/S0022-3476(88)80022-2
  12. Magliocca KR, Lewis EL, Bhattacharyya I, Cohen DM, Dixon LR. Labial salivary gland biopsy in the investigation of neonatal hemochromatosis. J Oral Maxillofac Surg 2011;69:2592-4. https://doi.org/10.1016/j.joms.2011.02.045
  13. Hayes AM, Jaramillo D, Levy HL, Knisely AS. Neonatal hemochromatosis: diagnosis with MR imaging. AJR Am J Roentgenol 1992;159:623-5. https://doi.org/10.2214/ajr.159.3.1503038
  14. Debray FG, de Halleux V, Guidi O, Detrembleur N, Gaillez S, Rausin L, et al. Neonatal liver cirrhosis without iron overload caused by gestational alloimmune liver disease. Pediatrics 2012;129:e1076-9. https://doi.org/10.1542/peds.2011-0568
  15. Rand EB, Karpen SJ, Kelly S, Mack CL, Malatack JJ, Sokol RJ, et al. Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin. J Pediatr 2009;155:566-71. https://doi.org/10.1016/j.jpeds.2009.04.012
  16. Sheflin-Findling S, Annunziato RA, Chu J, Arvelakis A, Mahon D, Arnon R. Liver transplantation for neonatal hemochromatosis: analysis of the UNOS database. Pediatr Transplant 2015;19:164-9. https://doi.org/10.1111/petr.12418
  17. Sundaram SS, Alonso EM, Whitington PF. Liver transplantation in neonates. Liver Transpl 2003;9:783-8. https://doi.org/10.1053/jlts.2003.50104
  18. Rodrigues F, Kallas M, Nash R, Cheeseman P, D'Antiga L, Rela M, et al. Neonatal hemochromatosis--medical treatment vs. transplantation: the king's experience. Liver Transpl 2005;11:1417-24. https://doi.org/10.1002/lt.20497
  19. Nijagal A, Fleck S, Hills NK, Feng S, Tang Q, Kang SM, et al. Decreased risk of graft failure with maternal liver transplantation in patients with biliary atresia. Am J Transplant 2012;12:409-19. https://doi.org/10.1111/j.1600-6143.2011.03895.x
  20. Sanada Y, Kawano Y, Miki A, Aida J, Nakamura K, Shimomura N, et al. Maternal grafts protect daughter recipients from acute cellular rejection after pediatric living donor liver transplantation for biliary atresia. Transpl Int 2014;27:383-90. https://doi.org/10.1111/tri.12273